Modern therapy in blepharospasm
Bereş, A.
Oftalmologia 54(1): 71-76
2010
ISSN/ISBN: 1220-0875 PMID: 20540373 Document Number: 639251
Pharmaceutical presentation of botulin A toxin (BAT) and its therapeutical use in ophthalmology in essential blepharospasm, as well. This work analyses the results and the disadvantages of the cure. During the last 3 years 21 patients suffering of essential blepharospasm have been cured. The cure with botulin A toxin administrated in efficient doses is followed by a 3-4 months period of pause. At all the patients cured with Dysport, the symptoms have improved or weakened. The cure should be done at least twice a year (from 6 to 6 months) due to the "sprouting" axonal phenomenon. The treatment of essential blepharospasm with botulin A toxin is a reliable and efficient method, with results relatively quickly installed. In treating this disease, it should be chosen from the very beginning.